Effects of GCN2 inhibitor GCN2iB on larval mortality of Cry1Ac-treated <i>H. armigera.</i> by Caihong Zhang (1633294)

The statistical data of the partial graph. by Si Yu Zhao (19544793)

Subjects:

Experimental Design Flowchart. by Si Yu Zhao (19544793)

Subjects:

Original uncropped Western blot images. by Yaping Yuan (2734228)

Subjects:

Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual). by Kirralise J. Hansford (20670869)

Subjects:

The sequences of si-RNAs used in this study. by Changji Li (4806930)

Subjects:

Fig 6 - by Kirralise J. Hansford (20670869)

Subjects:

Distribution of CRNN in normal epithelium and lesions in cSCC patients. by Changji Li (4806930)

Subjects:

CRNN over-expression promotes the growth of cSCC xenografts in vivo. by Changji Li (4806930)

Subjects:

Fig 5 - by Kirralise J. Hansford (20670869)

Subjects:

Fig 4 - by Kirralise J. Hansford (20670869)

Subjects:

Schematic of augmented reality system with tactile stimulator. by Kirralise J. Hansford (20670869)

Subjects:

Infographic of experimental conditions. by Kirralise J. Hansford (20670869)

Subjects:

Data. by Michael C. Payne (2664379)

Subjects:

Prevalence of <i>Wb</i> microfilaremia and circulating filarial antigenemia before and after MDA in annual and semiannual intervention areas. by Michael C. Payne (2664379)

Subjects:

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects:

Changes in circulating filarial antigen (CFA) prevalence and levels at years 1, 2, and 3 following the start of mass drug administration, with treatment given semiannually (2x/yr)... by Michael C. Payne (2664379)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)